Lanwei Ouyang

Papers

Total Citations

125

H-Index

About

Lanwei Ouyang is a leading voice in the rapidly evolving field of minimally invasive oncologic surgery, with a particular focus on thoracic and hepatopancreaticobiliary procedures. Dr. Ouyang’s research is dedicated to comparing the safety and efficacy of competing surgical platforms, specifically robotic-assisted (RATS) versus video-assisted thoracoscopic surgery (VATS) for lung cancer, and robotic versus laparoscopic approaches for complex pancreatic resections. In a landmark 2022 systematic review and meta-analysis, Dr. Ouyang provided a critical, updated evaluation of RATS and VATS for lobectomy and segmentectomy, synthesizing data to clarify long-term and short-term outcomes for lung cancer patients. This work, which has garnered over 70 citations, is complemented by a similarly impactful meta-analysis comparing robotic and laparoscopic pancreaticoduodenectomy, a procedure of exceptional technical difficulty. By rigorously analyzing these minimally invasive techniques, Dr. Ouyang’s research directly informs surgical decision-making and helps define best practices for improving patient recovery and survival. With over 125 combined citations on these two pivotal studies alone, Dr. Ouyang is establishing a reputation for producing high-quality, evidence-based comparisons that shape the future of surgical oncology.